Medindia

X

Sun Pharma Issues Recall for Two Drugs in US Market

by Kathy Jones on  May 9, 2014 at 9:20 PM Drug News   - G J E 4
Trouble deepened for Mumbai-based Sun Pharmaceuticals after it was forced to recall over 4 lakh bottles of anti-depressant and anti-allergy drugs from the American market as they failed to meet specifications.
 Sun Pharma Issues Recall for Two Drugs in US Market
Sun Pharma Issues Recall for Two Drugs in US Market
Advertisement

The company confirmed that it has recalled bottles of anti-depressant Venlafaxine Hydrochloride and anti-allergy Cetirizine Hydrochloride that were manufactured by its US subsidiary, Caraco Pharmaceutical Laboratories.

Advertisement
According to the FDA website, around 1,28,363 bottles of Cetirizine Hydrochloride chewable tablets of 5 mg strength and another lot of 47,813 bottles of the same drug of 10 mg dosage and 1,60,105 bottles of Venlafaxine Hydrochloride extended release tablets of 150 mg strength and 91,777 bottles of 37.5 mg strength failed to meet the drug specifications.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like